ArticleNeurology(R) neuroimmunology & neuroinflammation2022

Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS.

Nicola de Stefano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.